Md. Code Regs. 10.34.35.04

Current through Register Vol. 51, No. 24, December 2, 2024

Section 10.34.35.04 - Pharmacist Responsibilities

A. A pharmacist in an infusion pharmacy shall adhere to the policies and procedures set forth in Regulation .06 of this chapter.

B. A pharmacist shall:

(1) Provide infusion therapy services in accordance with:

(a) Orders issued by a licensed authorized prescriber of record; and

(b) Where applicable, protocols issued by a licensed authorized prescriber of record.

(2) Perform and document initial and ongoing assessments of the appropriateness of infusion therapy using the following information:

(a) Patient demographics including:

(i) Name;

(ii) Address;

(iii) Telephone number;

(iv) Gender; and

(v) Date of birth;

(b) Emergency contact information;

(c) Diagnoses, including:

(i) Diagnosis being treated; and

(ii) Concurrent conditions, including pregnancy and lactation status if applicable;

(d) Medical history;

(e) Allergies;

(f) If applicable, height;

(g) Weight;

(h) Parenteral medication orders, including length of therapy;

(i) Parenteral infusion access device:

(i) Location;

(ii) Type; and

(iii) If available, date of placement;

(j) Ongoing medication profile review and reconciliation at end of therapy;

(k) First dose status;

(l) Caregiver information including, but not limited to:

(i) Name;

(ii) Address;

(iii) Phone number; and

(iv) Relationship to patient;

(m) If applicable, contact information for other agencies or individuals involved in the patient's home care;

(n) Documented applicable medical and social factors and functional limitations which may affect infusion therapy including but not limited to:

(i) Language;

(ii) Sight;

(iii) Hearing;

(iv) History of IV drug abuse;

(v) History of drug or alcohol abuse; or

(vi) Other physical or mental limitations; and

(o) If applicable to therapy, baseline labs;

(3) Create a patient care plan specific to the patient's:

(a) Diagnosis;

(b) Prescribed therapy; and

(c) Concurrent conditions;

(4) When compounding sterile preparations, comply with COMAR 10.34.19;

(5) If sterile compounding is outsourced, comply with COMAR 10.34.04;

(6) As applicable, retrieve and assess lab values and other monitoring parameters;

(7) Document in the patient chart:

(a) New prescription orders;

(b) Changes in prescription orders;

(c) Information obtained from the patient or caregiver; and

(d) Other necessary information obtained from the:

(i) Patient;

(ii) Caregiver;

(iii) Infusion nurse;

(iv) Licensed authorized prescriber of record; or

(v) Other sources relevant to patient care;

(8) Verify prescription label accuracy;

(9) Communicate as appropriate, throughout the patient's therapy with the:

(a) Licensed authorized prescriber of record or agent of the licensed authorized prescriber of record;

(b) Patient's infusion nurse;

(c) Patient; and

(d) Caregiver; and

(10) Review therapy-specific considerations such as pain and nutrition status.

Md. Code Regs. 10.34.35.04